Pharmafit Provence
HYLOVIS S ophtalm lubricating for ocular instillation 20Unidoses/0,3ml
Back to the catalogue

HYLOVIS S ophtalm lubricating for ocular instillation 20Unidoses/0,3ml

VIDAL information
Your professional account

PharmaFit supplies pharmacies and healthcare professionals. Access your purchasing terms and availability through your professional account.

Access is reserved for authorised professionals, following account approval.

Contact PharmaFit

Product information

Find indications, dosage and precautions in the sections below.

Automatic English translation of the French VIDAL document. Original numerical values and units are retained, including decimal commas.

VIDAL
Parapharmacy
Update of 05/08/2026

CE HYLOVIS®, HYLOVIS® MULTI 15 ocular solution
sodium hyaluronate at 0,18 %

Forms and presentations 

Sterile solution for topical ophthalmic use:  
  • Hylovis: Box of 20 unidoses of 0,3 ml (ACL 3401046071189).
  • Hylovis Multi 15: Multidose bottle of 15 ml without preservative (EAN 3760054330016).

Composition 

Sodium hyaluronate: 1,8 mg/ml ; chlorides of sodium, of potassium, of magnesium, of calcium ; disodium hydrogen phosphate ; sodium citrate ; water for injectable preparation. Without preservative agent. The solution is hypotonic.

Properties 

Hylovis and Hylovis Multi 15 contain hyaluronic acid, a natural polymer also present in the structures of the human eye. The particular physical characteristics of hyaluronic acid confer to Hylovis and Hylovis Multi 15 their important « viscoelastic » properties and water retention. Hylovis and Hylovis Multi 15 thus form a stable film on the surface of the eye which is only slowly eliminated by blinking. Hylovis and Hylovis Multi 15 thus combine a prolonged effect with maximum comfort. Due to their particular composition, Hylovis and Hylovis Multi 15 are very well tolerated. They do not contain preservative.

Indications 

Moderate and severe sensations of ocular dryness.

Directions for use 

Unidose form:
  • Turn and detach the upper part to open.
  • Tilt the head backwards and position the tip of the bottle above the eye to be treated.
  • Pull the lower eyelid down with the index finger of one hand.
  • Press on the unidose and a drop of Hylovis will flow easily.
Unless otherwise recommended, instill 1 to 2 drop(s) of Hylovis in the eye as often as necessary.
A few blinks of the eyelids will ensure uniform distribution of the solution on the ocular surface in a transparent and durable film.
 
Multidose form:
  • Remove the tamper-evident ring before first administration.
  • Remove the protective cap.
  • Tilt the head backwards and position the tip of the bottle above the eye to be treated.
  • Pull the lower eyelid down with the index finger of one hand.
  • Press on the body of the bottle and a drop of Hylovis Multi will flow easily.
Unless otherwise recommended, instill 1 to 2 drop(s) of Hylovis Multi in the eye as often as necessary.
A few blinks of the eyelids will ensure uniform distribution of the solution on the ocular surface in a transparent and durable film.
 
Hylovis and Hylovis Multi 15 may be used during the wearing of contact lenses, whatever the type (soft or rigid).

Contraindications 

Hypersensitivity to one of the components of the product.

Precautions for use 

If disorders persist during the use of Hylovis or Hylovis Multi 15, consult a physician.

Keep out of the reach of children.

  • Unidose form :
    Do not touch the open part of the single-dose container with the fingers and avoid direct contact with the eye. Do not use Hylovis if the single-dose container is damaged. As Hylovis does not contain a preservative, do not reuse the contents of the single-dose container after opening.
  • Multidose form:
    Do not touch the tip of the open bottle and do not touch the surface of the eye with the tip of the bottle. Replace the protective cap of Hylovis Multi 15 after use. Do not use Hylovis Multi 15 if the bottle is damaged. Hylovis Multi 15 may be used up to 6 months after first use.

Store between + 2 °C and + 30 °C.

Adverse effects
In very rare cases, transient disorders such as conjunctival irritation, a foreign body sensation, redness or a burning sensation of the eye, as well as momentarily blurred vision may appear.
Concomitant treatment at risk of interaction:
Do not administer Hylovis or Hylovis Multi 15 at the same time as other ophthalmic products or medicines, as they could modify their effects.

ADMINISTRATIVE INFORMATION 

LPPR rate:
2,91 euros (Hylovis: 20 single-dose containers of 0,3 ml), LPPR code 1146190.
8,75 euros (Hylovis Multi 15: bottle of 15 ml), LPPR code 1130124.
Maximum public selling price:12,14 euros (Hylovis Multi 15).

AAD Service Code.
 
Reimbursed indication:
Symptomatic treatment of dry eye with keratitis or keratoconjunctivitis sicca, as third-line treatment after failure of low-viscosity tear substitutes and gels (carbomer type).
In this indication, the use of Hylovis and Hylovis Multi is not indicated in patients wearing contact lenses.
 
Prescription and use modalities:
- prescription by an ophthalmologist after diagnosis of keratitis or keratoconjunctivitis sicca, notably by a colorimetric test performed with a slit lamp;
- initial prescription not to exceed 6 months of treatment. At the end of this period, re-evaluation ideally by an ophthalmologist for possible renewal of prescription.

Medical device, class IIb CE 0123.
 
Manufacturer: TRB Chemedica AG, Otto-Lilienthal-Ring 26, 85622 Feldkirchen/München, Germany.

TRB CHEMEDICA SAS
ArchParc, ActiTech 4
60, Marie-Curie Avenue
CS 40218. 74160 Archamps
Tel: 04 50 95 09 00
https://trbchemedica.fr/

Source: VIDAL · Updated on 10/11/2026. This information does not replace advice from a healthcare professional.